Direct comparison
Covidence vs Rayyan vs DistillerSR
Covidence vs. Rayyan vs. DistillerSR compared: screening, dedup, PRISMA diagrams, extraction, licensing, and regulatory audit trails.
Ask about Covidence vs Rayyan vs DistillerSR
Answers are drawn from this comparison and the rest of the CASRAI corpus, with a link to every source.
Answers are AI-generated from CASRAI’s own published pages and can be wrong, so check the linked sources before relying on one; your question is logged without personal data — never sold, never used to train a third-party model — to show us what CASRAI is missing, so please do not type personal or confidential details. How we use this
How do Covidence, Rayyan, DistillerSR compare side by side?
The table below compares Covidence, Rayyan, DistillerSR across 11 procurement-relevant dimensions, from best known for through best fit.
Side-by-side comparison
| Dimension | Covidence | Rayyan | DistillerSR |
|---|---|---|---|
| Best known for | Cochrane-aligned, full screening-to-extraction workflow | Free, AI-assisted title/abstract screening | Regulatory and HTA-grade audit trails and extraction |
| Screening model | Blind dual-review with automatic conflict flagging + third-reviewer resolution | Blind dual (or multi-) reviewer screening with ML queue re-ranking | Blind dual-review with configurable multi-level forms and disagreement-triggered rules |
| Deduplication | Automated match on import; flags likely duplicates for manual confirmation | Automated match on import plus manual merge for missed near-duplicates | Automated match on import; flags likely duplicates for manual confirmation |
| PRISMA flow diagram | Built-in, auto-generated from screening counts | Generated from screening decision counts | Included in broader audit-trail reporting suite |
| Data extraction | Built-in customizable extraction forms + RoB 2/ROBINS-I appraisal | Not included — export to a separate extraction tool | Fully custom forms with conditional/branching logic and multi-reviewer reconciliation |
| Collaboration / team size | Small-to-mid team, one review at a time per license | Multiple reviewers per review at no cost; org-wide team tools are paid | Built for many concurrent reviews with project/role-level permissions |
| Access model | Paid subscription, per review or per institution | Free core screening; paid tiers for AI features and heavier usage | Enterprise licensing, sold to organizations |
| Cochrane affiliation | Cochrane's recommended screening tool; widely used by Cochrane review groups | No formal Cochrane affiliation | No formal Cochrane affiliation |
| Regulatory / audit-trail support | Decision-level audit trail; not marketed for regulatory submissions | Decision-level audit trail; not marketed for regulatory submissions | Vendor-documented controls aligned with FDA 21 CFR Part 11 / EU Annex 11 expectations |
| Export / interoperability | CSV/RIS export; structured extraction data exportable to meta-analysis tools | CSV/RIS export of screening decisions and references | CSV/RIS export; structured extraction data exportable to meta-analysis tools |
| Best fit | Cochrane or Cochrane-style reviews; teams wanting one tool end-to-end | Students, solo researchers, unfunded or first-time reviews | Regulatory/HTA submissions, CROs, high-volume review programs |
Common questions
Common questions about Covidence vs Rayyan vs DistillerSR
Is Rayyan really free?
+
Core screening — unlimited reviews, multiple reviewers per review, blind dual screening, and ML-assisted queue ranking — is free. Paid tiers add features like PICO-based filtering and higher usage limits, but a full systematic review can be screened on the free tier.
Does Cochrane require Covidence specifically?
+
Cochrane recommends Covidence and many of its review groups use it as their standard tool, but Cochrane does not contractually require a specific screening platform — the requirement is that the review follows Cochrane Handbook methodology, which any of these three tools can support.
Can I switch tools partway through a review?
+
Technically yes, via RIS/CSV export and re-import, but switching mid-screening risks losing in-progress conflict-resolution state and re-triggering deduplication — most teams pick one tool before screening starts specifically to avoid this.
Do any of these tools perform the meta-analysis itself?
+
No. All three manage screening and (for Covidence and DistillerSR) extraction, but the statistical synthesis step happens in dedicated meta-analysis software after data is exported.
Going deeper
